Suppression of GSK-3 by treatment with the GSK-3 inhibitor SB415286 suppressed motility, proliferation and colony formation in PC3 prostate cancer cells which express large amounts of activated Akt due to PTEN deletion. Here, AKT1 is linked to Familial prostate cancer.